test Browse by Author Names Browse by Titles of Works Browse by Subjects of Works Browse by Issue Dates of Works

Advanced Search
& Collections
Issue Date   
Sign on to:   
Receive email
My Account
authorized users
Edit Profile   
About T-Space   

T-Space at The University of Toronto Libraries >
School of Graduate Studies - Theses >
Master >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1807/32236

Title: V-ATPase a3-d2 and a3-B2 Subunit Interaction in Osteoclasts are Viable Targets for Anti-resorptive Therapeutics
Authors: Crasto, Gazelle Jean
Advisor: Manolson, Morris Frank
Department: Dentistry
Keywords: Bone
drug development
Issue Date: 21-Mar-2012
Abstract: For bone resorption, vacuolar-type H+-ATPases (V-ATPases) on the plasma membranes of osteoclasts acidifies the extracellular millieu adjacent to the bone surface. The V-ATPase a3 and d2 subunits are enriched in osteoclasts. B2 subunit is also expressed on the osteoclast plasma membrane. Disruption of genes encoding subunits a3 and d2 impairs bone resorption. In this study, we have shown an interaction between the a3-B2 and a3-d2 subunits. Luteolin and KM91104 were found to be effective inhibitors of the a3-d2 and a3-B2 interactions respectively. Secondary assays revealed luteolin and KM91104 were not toxic to cells, did not affect osteoclastogenesis yet inhibited bone resorption. Furthermore luteolin did not affect V-ATPase subunit formation or assembly. Inhibitors of osteoclast resorption that do not affect osteoclast viability, preserve osteoclast–osteoblast signalling are desirable than existing anti-resorptives. Therefore, V-ATPase a3–d2 and a3-B2 interactions are viable targets for anti-resorptive therapeutics for osteoporosis.
URI: http://hdl.handle.net/1807/32236
Appears in Collections:Master

Files in This Item:

File Description SizeFormat
Crasto_Gazelle_J_201203_MSc_thesis.pdf5.26 MBAdobe PDF

Items in T-Space are protected by copyright, with all rights reserved, unless otherwise indicated.